Inactive Instrument
Guardion Health Sciences, Inc. Share Price
Stocks
GHSI
US40145Q5009
Pharmaceuticals
OTC Markets Traded| 1 day | -2.13% |
| 3 years | 3.04 |  | 18 |
| 5 years | 3.04 | | 99 |
| 10 years | 3.04 | | 1,200 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Goldstone
CEO | Chief Executive Officer | 62 | 17/10/2024 |
| Corporate Secretary | 74 | - | |
Susan Klein
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 74 | 30/06/2020 | |
Mark Goldstone
BRD | Director/Board Member | 62 | 31/05/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 26/08/24 | Sell | 115,540 | 8.9973% | |||
| 28/03/24 | Great Point Capital LLC
| Other | Company | 159,652 | 12.5194% | |
| 30/06/23 | Free | Director | 334 | 0.0264% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.13% | -.--% | - | - | 4.35M | |
| +3.19% | +11.31% | +67.86% | +150.58% | 1,263B | |
| -0.73% | +3.56% | +44.51% | +85.81% | 658B | |
| +1.41% | +3.24% | +29.22% | +107.83% | 521B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 391B | |
| +2.18% | +2.93% | +73.30% | +45.62% | 369B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 307B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 290B | |
| +1.15% | +6.09% | +59.59% | +77.06% | 252B | |
| +3.06% | +9.38% | +44.11% | +119.47% | 212B | |
| Average | +1.34% | +5.90% | +46.59% | +83.14% | 473.55B | |
| Weighted average by Cap. | +1.19% | +6.60% | +50.88% | +98.31% |
Employees
9
Sector
Pharmaceuticals
